Pharmacoepidemiology and drug safety

Keyphrases

Publications

volume 33, number 8, 2024

Todd R Sponholtz, Aziza Jamal-Allial, Shiva K Vojjala, Anahit Papazian, Biruk Eshete, Mark Paullin, Seyed Hamidreza Mahmoudpour, Patrice Verpillat, Daniel C Beachler
Trends in the Completeness and Validity of Sources of Death Data Against the National Death Index From 2010 to 2018. Pharmacoepidemiology and drug safety 33 (8) (2024)
Zeyu Wang, Tangyi Liu, Qiaoyu Su, Hui Luo, Lijun Lou, Lina Zhao, Xiaoyu Kang, Yanglin Pan, Yongzhan Nie
Prevalence of Polypharmacy in Elderly Population Worldwide: A Systematic Review and Meta-Analysis. Pharmacoepidemiology and drug safety 33 (8) (2024)
Kathrin Jobski, Michaela Ritschel, Katja Pöggel-Krämer, Daniela Anheier, Burkhard Haastert, Veronika Gontscharuk, Werner Arend, Marion Baltes, Astrid Stephan, Gabriele Meyer, Birgit Klüppelholz, Joachim Windolf, Simon Thelen, Carina Jaekel, Silke Andrich, Andrea Icks, Falk Hoffmann
Pain Medication and Pain Intensity Following Hip Fractures-Analyses Based on the ProFem Cohort Study. Pharmacoepidemiology and drug safety 33 (8) (2024)
Xuya Xiao, G Caleb Alexander, Hemalkumar B Mehta
Nirmatrelvir/Ritonavir (Paxlovid) Use Among Individuals at Risk of Severe COVID-19: An Analysis of the National COVID Cohort Collaborative (N3C). Pharmacoepidemiology and drug safety 33 (8) (2024)
Brianna Costales, Scott Martin Vouri, Joshua D Brown, Barry Setlow, Amie J Goodin
Risk of Suicidal Ideation and Behavior Following Early-Onset Idiopathic Restless Legs Syndrome Treatment. Pharmacoepidemiology and drug safety 33 (8) (2024)
Brianna Costales, Scott Martin Vouri, Joshua D Brown, Barry Setlow, Amie J Goodin
Risk of Suicidal Ideation and Behavior Following Early-Onset Idiopathic Restless Legs Syndrome Treatment. Pharmacoepidemiology and drug safety 33 (8) (2024)
Matthew R Muschett, Celeste Lom Ying Ewig, Earl J Morris, Lauren E Adkins, Amie J Goodin, Joshua Brown
A Review of Concordance and Quality in Clinical Guidelines for Hormonal Contraceptives to Mitigate Drug-Drug Interactions in Women With Epilepsy. Pharmacoepidemiology and drug safety 33 (8) (2024)
Shahrzad Salmasi, Samuel Igweokpala, Antonios Douros, Nehal Islam, Jason G Andrade, Kristian B Filion
Opioid Use and the Risk of Ventricular Arrhythmias: A Systematic Review and Meta-Analysis. Pharmacoepidemiology and drug safety 33 (8) (2024)
Milad Sadreghaemy, Magdalena A Gamba, Lourens T Bloem, Antoine C G Egberts
Leftover of Amoxicillin Suspension After Use by Children in the Netherlands. Pharmacoepidemiology and drug safety 33 (8) (2024)
Shahd A Ageeb, Alaa Abdelmoghith, Hager ElGeed, Ahmed Awaisu, Abdulmoniem ElMansor, Yaw B Owusu
Prevalence, Associated Risk Factors, and Adverse Cardiovascular Outcomes of Statins Discontinuation: A Systematic Review. Pharmacoepidemiology and drug safety 33 (8) (2024)
Jihyun Lee, Pusoon Chun
Real world prescription of beta-blockers in patients with asthma. Pharmacoepidemiology and drug safety 33 (8) (2024)
Priyanka Anand, Elvira D'Andrea, William Feldman, Shirley V Wang, Jun Liu, Gregory Brill, Elyse DiCesare, Kueiyu Joshua Lin
A Dynamic Prognostic Model for Identifying Vulnerable COVID-19 Patients at High Risk of Rapid Deterioration. Pharmacoepidemiology and drug safety 33 (8) (2024)
Xuya Xiao, G Caleb Alexander, Hemalkumar B Mehta
Nirmatrelvir/Ritonavir (Paxlovid) Use Among Individuals at Risk of Severe COVID-19: An Analysis of the National COVID Cohort Collaborative (N3C). Pharmacoepidemiology and drug safety 33 (8) (2024)
Brianna Costales, Scott Martin Vouri, Joshua D Brown, Barry Setlow, Amie J Goodin
Risk of Suicidal Ideation and Behavior Following Early-Onset Idiopathic Restless Legs Syndrome Treatment. Pharmacoepidemiology and drug safety 33 (8) (2024)
Xuya Xiao, G Caleb Alexander, Hemalkumar B Mehta
Nirmatrelvir/Ritonavir (Paxlovid) Use Among Individuals at Risk of Severe COVID-19: An Analysis of the National COVID Cohort Collaborative (N3C). Pharmacoepidemiology and drug safety 33 (8) (2024)
Frank Peinemann, Doris Oberle, Ursula Drechsel-Bäuerle, Brigitte Keller-Stanislawski
Adverse Menstrual Events Reported After and Before (or Without) COVID-19 Vaccination: A Systematic Review and Meta-Analysis of Comparative Observational Studies. Pharmacoepidemiology and drug safety 33 (8) (2024)
Matthew R Muschett, Celeste Lom Ying Ewig, Earl J Morris, Lauren E Adkins, Amie J Goodin, Joshua Brown
A Review of Concordance and Quality in Clinical Guidelines for Hormonal Contraceptives to Mitigate Drug-Drug Interactions in Women With Epilepsy. Pharmacoepidemiology and drug safety 33 (8) (2024)
Anne M Suffel, Jemma L Walker, Colin Campbell, Helena Carreira, Charlotte Warren-Gash, Helen I McDonald
A New Validated Approach for Identifying Childhood Immunizations in Electronic Health Records in the United Kingdom. Pharmacoepidemiology and drug safety 33 (8) (2024)
Xinyue Liu, Golnoosh Haris Alipour, Changxia Shao, Mehmet Burcu, Edward Bortnichak, Thao Vo, Chu-Ling Yu
The Comparison of Newly Diagnosed Invasive Breast Patient Cohorts in Genomics Evidence Neoplasia Information Exchange Biopharma Collaborative (GENIE-BPC) and Other Real-World Databases. Pharmacoepidemiology and drug safety 33 (8) (2024)
Romin Pajouheshnia, Rosa Gini, Lia Gutiérrez, Morris A Swertz, Eleanor Hyde, Miriam C J M Sturkenboom, Alejandro Arana, Carla Franzoni, Vera Ehrenstein, Giuseppe Roberto, Miguel Gil, Miguel-Angel Maciá-Martínez, Wiebke Schäfer, Ulrike Haug, Nicolas H Thurin, Régis Lassalle, Cécile Droz-Perroteau, Silvia Zaccagnino, Maria Paula Busto, Bas Middelkoop, Karin Gembert, Francisco Sanchez-Saez, Clara L Rodríguez-Bernal, Gabriel Sanfélix-Gimeno, Isabel Hurtado, Manuel Barreiro-de Acosta, Beatriz Poblador-Plou, Jonás Carmona Píréz, Antonio Gimeno-Miguel, Alexandra Prados-Torres, Anna Schultze, Ella Jansen, Ron M C Herings, Josephina G Kuiper, Igor Locatelli, Janja Jazbar, Špela Žerovnik, Mitja Kos, Steven Smit, Sirje Lind, Andres Metspalu, Stefania Simou, Karin Hedenmalm, Ana Cochino, Paolo Alcini, Xavier Kurz, Susanna Perez-Gutthann
Metadata for Data dIscoverability aNd Study rEplicability in obseRVAtional Studies (MINERVA): Development and Pilot of a Metadata List and Catalogue in Europe. Pharmacoepidemiology and drug safety 33 (8) (2024)
Thomas G Boyce, David L McClure, Kayla E Hanson, Matthew F Daley, Malini B DeSilva, Stephanie A Irving, Lisa A Jackson, Nicola P Klein, Bruno J Lewin, Joshua T B Williams, Jonathan Duffy, Michael M McNeil, Eric S Weintraub, Edward A Belongia
Lack of Evidence for Vaccine-Associated Enhanced Disease From COVID-19 Vaccines Among Adults in the Vaccine Safety Datalink. Pharmacoepidemiology and drug safety 33 (8) (2024)
Shahrzad Salmasi, Samuel Igweokpala, Antonios Douros, Nehal Islam, Jason G Andrade, Kristian B Filion
Opioid Use and the Risk of Ventricular Arrhythmias: A Systematic Review and Meta-Analysis. Pharmacoepidemiology and drug safety 33 (8) (2024)
Shahd A Ageeb, Alaa Abdelmoghith, Hager ElGeed, Ahmed Awaisu, Abdulmoniem ElMansor, Yaw B Owusu
Prevalence, Associated Risk Factors, and Adverse Cardiovascular Outcomes of Statins Discontinuation: A Systematic Review. Pharmacoepidemiology and drug safety 33 (8) (2024)
Helga Zoega, Michael O Falster, Malcolm Bjørn Gillies, Melisa Litchfield, Ximena Camacho, Claudia Bruno, Benjamin Daniels, Natasha Donnolley, Alys Havard, Andrea L Schaffer, Georgina M Chambers, Louisa Degenhardt, Timothy A Dobbins, Natasa Gisev, Rebecca Q Ivers, Louisa R Jorm, Bette Liu, Claire M Vajdic, Sallie-Anne Pearson
The Medicines Intelligence Data Platform: A Population-Based Data Resource From New South Wales, Australia. Pharmacoepidemiology and drug safety 33 (8) (2024)
Thomas Goedecke, Liana Gross-Martirosyan, Nathalie Gault, Karin Seifert, Daniel R Morales, Priya Bahri, Valerie Strassmann, Martin Huber, Sabine Straus
Studying the Impact of European Union Regulatory Interventions for Minimising Risks From Medicines: Lessons Learnt and Recommendations. Pharmacoepidemiology and drug safety 33 (8) (2024)
Aaron Jun Yi Yap, Desmond Chun Hwee Teo, Pei San Ang, Eng Soo Yap, Siew Har Tan, Celine Wei Ping Loke, Sreemanee Raaj Dorajoo
Validation of a Major and Clinically Relevant Nonmajor Bleeding Phenotyping Algorithm on Electronic Health Records. Pharmacoepidemiology and drug safety 33 (8) (2024)
Frank Peinemann, Doris Oberle, Ursula Drechsel-Bäuerle, Brigitte Keller-Stanislawski
Adverse Menstrual Events Reported After and Before (or Without) COVID-19 Vaccination: A Systematic Review and Meta-Analysis of Comparative Observational Studies. Pharmacoepidemiology and drug safety 33 (8) (2024)
Pär Karlsson, Karin Gembert, Suzan Esslinger, Anja Geldhof, Gissler Mika, Maarit K Leinonen, Marijo Otero-Lobato, Lars Pedersen, Carolyn E Cesta
Pregnancy and Infant Outcomes After Prenatal Exposure to Golimumab in Denmark, Finland, and Sweden 2006-2019. Pharmacoepidemiology and drug safety 33 (8) (2024)
Minako Matsumoto, Sei Harada, Harufumi Ikuta, Miho Iida, Suzuka Kato, Mizuki Sata, Takuma Shibuki, Yoshiki Ishibashi, Naoko Miyagawa, Moeko Hisamatsu, Aya Hirata, Kazuyo Kuwabara, Ayano Takeuchi, Daisuke Sugiyama, Sayo Suzuki, Tomonori Nakamura, Tomonori Okamura, Toru Takebayashi
Evaluation of Medication Adherence Among Prevalent Users in Hypertension, Dyslipidemia, and Diabetes Using Health Insurance Claims: A Population-Based Cohort Study in Japan. Pharmacoepidemiology and drug safety 33 (8) (2024)
Tiansheng Wang, Dongze Ji, Til Stürmer, Sherine Ismail, Shujie Dong, Peng Shen, Hongbo Lin, Luwen Shi, Xiaodong Guan, Yang Xu
The Effect of Sodium Glucose Cotransporter-2 Inhibitors on Hemoglobin A1c Variability and Acute Kidney Injury: A Causal Mediation Analysis. Pharmacoepidemiology and drug safety 33 (8) (2024)
Mengyuan Fu, Zhiwen Gong, Yuezhen Zhu, Can Li, Huangqianyu Li, Lu-Wen Shi, Xiaodong Guan
Disparity in Guideline-Based Antidiabetic Drugs Prescribing for Type 2 Diabetes Patients in Primary Healthcare Facilities Across China, 2017-2019. Pharmacoepidemiology and drug safety 33 (8) (2024)
Zeyu Wang, Tangyi Liu, Qiaoyu Su, Hui Luo, Lijun Lou, Lina Zhao, Xiaoyu Kang, Yanglin Pan, Yongzhan Nie
Prevalence of Polypharmacy in Elderly Population Worldwide: A Systematic Review and Meta-Analysis. Pharmacoepidemiology and drug safety 33 (8) (2024)

volume 33, number 9, 2024

Tamino Zappalà, Jesper Hallas, Carola A Huber, Daphne Reinau, Christoph R Meier, Julia Spoendlin
Changes in the Use of Hydrochlorothiazide and Other Antihypertensive Drugs in Switzerland in Association With the Swissmedic Safety Alert Regarding Non-melanoma Skin Cancer: An Interrupted Time-Series Analysis Using Swiss Claims Data. Pharmacoepidemiology and drug safety 33 (9) (2024)
Julien Kirchgesner, Shirley V Wang, Sebastian G Schneeweiss
Strengthening Real-World Evidence on Question Not Answered by Randomized Trials: A Trial Calibration Approach. Pharmacoepidemiology and drug safety 33 (9) (2024)
Jessica A Perhanidis, Linda Kalilani, Nicole M Zimmerman, Amanda Golembesky
An Emulated Target Trial Case Study of Real-World Overall Survival With Second-Line Maintenance Niraparib Versus Active Surveillance in Patients With Recurrent Ovarian Cancer. Pharmacoepidemiology and drug safety 33 (9) (2024)
Lingjie Shen, Erik Visser, Felice van Erning, Gijs Geleijnse, Maurits Kaptein
A Two-Step Framework for Validating Causal Effect Estimates. Pharmacoepidemiology and drug safety 33 (9) (2024)
Kazuhiro Kajiyama, Maki Komamine, Naoya Horiuchi, Toyotaka Iguchi, Yoshiaki Uyama
PMDA Perspective on RWD/RWE Utilization for Regulatory Purposes Including Assessment on the Impacts of Regulatory Actions and Safety Risk of a Drug at Postmarketing Stage. Pharmacoepidemiology and drug safety 33 (9) (2024)
Haerin Cho, Eunsun Lim, Hee-Jin Kim, Na-Young Jeong, Nam-Kyong Choi
Association Between Influenza Vaccination and Acute Kidney Injury Among the Elderly: A Self-Controlled Case Series. Pharmacoepidemiology and drug safety 33 (9) (2024)
Chase D Latour, I-Hsuan Su, Megan Delgado, Virginia Pate, Charles Poole, Jessie K Edwards, Til Stürmer, Jennifer L Lund, Michele Jonsson Funk
Hazard Ratios and Alternative Effect Measures: An Applied Illustration. Pharmacoepidemiology and drug safety 33 (9) (2024)
Dony Patel, Sonia Guleria, Lina Titievsky, Susanna Flaherty, Nicholas Everage, Marta Korjagina, Sheuli Porkess, Tzuyung Douglas Kou, Deborah Layton
Contemporary Practice and Considerations for Real-World Data Source Identification and Feasibility Assessment. Pharmacoepidemiology and drug safety 33 (9) (2024)
Samantha Lane, Elizabeth Lynn, Saad Shakir
Quantitative Measurement of the Direct Public Health Impact of Medicines Withdrawals in Europe: Development of a Modelling Method and Proof-of-Concept Study to Estimate the Morbidity and Mortality Prevented by Regulatory Action. Pharmacoepidemiology and drug safety 33 (9) (2024)
John Tazare, Shirley V Wang, Rosa Gini, Daniel Prieto Alhambra, Peter Arlett, Daniel R Morales Leaver, Caroline Morton, John Logie, Jennifer Popovic, Katherine Donegan, Sebastian G Schneeweiss, Ian Douglas, Anna Schultze
Sharing Is Caring? International Society for Pharmacoepidemiology Review and Recommendations for Sharing Programming Code. Pharmacoepidemiology and drug safety 33 (9) (2024)
Mikkel Zöllner Ankarfeldt, Aleksander Søltoft-Jensen, Claudia A Salinas, Angela Lupattelli, Eero Pukkala, Kristian Bolin, Sarah Smith, Kristin Joy Meyers, Janne Petersen, Espen Jimenez-Solem
Effectiveness of Baricitinib Risk Minimization Activities in Patients With Rheumatoid Arthritis-A Cohort Study in Four Nordic Countries. Pharmacoepidemiology and drug safety 33 (9) (2024)
Maeve E Wickham, Kimberlyn M McGrail, Michael R Law, Amber Cragg, Corinne M Hohl
Re-Exposure to Culprit Medication Following Adverse Drug Event Diagnosis in Canadian Emergency Department Patients: A Cohort Study. Pharmacoepidemiology and drug safety 33 (9) (2024)
Hedvig Marie Egeland Nordeng, Angela Lupattelli, Hilde Marie Engjom, Marleen M H J van Gelder
Detecting and Dating Early Non-live Pregnancy Outcomes: Generation of a Novel Pregnancy Algorithm From Norwegian Linked Health Registries. Pharmacoepidemiology and drug safety 33 (9) (2024)
Paulette Negron Ericksen, Firas Dabbous, Rajrupa Ghosh, Surbhi Shah, Xunming Sun, Emily Riehm Meier, Carmine Colavecchia
Standardization of coding definitions for sickle cell disease complications: A systematic literature review. Pharmacoepidemiology and drug safety 33 (9) (2024)
Betty Chia-Chen Chang, I-Hua Lai, Yee-Yung Ng, Shiao-Chi Wu
Potentially Inappropriate Medication Use in Older Adults With Multimorbidity in Taiwan. Pharmacoepidemiology and drug safety 33 (9) (2024)
Marta Monreal-Di Bello, Diana González-Bermejo, Belén Castillo-Cano, Alfonso Rodriguez-Pascual, Dolores Montero-Corominas
Impact of Regulatory Interventions on Ulipristal Acetate 5 mg (Esmya) Use in Spain: An Interrupted Time-Series Analysis. Pharmacoepidemiology and drug safety 33 (9) (2024)
Pili Chih-Min Mao, Mei-Ing Chung, Yao-Min Hung, Hsiu-Min Chen, Chien-Liang Chen
Acarbose might be associated with reduced risk of gastric cancer in patients with diabetes mellitus: A nationwide population-based cohort study. Pharmacoepidemiology and drug safety 33 (9) (2024)
Efe Eworuke, Mayura U Shinde, Laura Hou, J Michael Paterson, Peter Bjødstrup Jensen, Judith C Maro, Ashish Rai, Jesper Hallas, Daniel Scarnecchia, Yuanling Liang, Deborah Johnson, Robert W Platt, Hana Lee, Marie C Bradley
Exposure to Valsartan Products Containing Nitrosamine Impurities in the United States, Canada, and Denmark. Pharmacoepidemiology and drug safety 33 (9) (2024)